Validated ligand binding sites in CCK receptors. next step: computer-aided design of novel CCK ligands.
Computer-aided drug design becomes an important part of G-protein coupled receptors (GPCR) drug discovery process that is applied for improving the efficiency of derivation and optimization of novel ligands. It represents the combination of methods that use structural information of a receptor binding site of known ligands to design new ligands. In this report, we give a brief description of ligand binding sites in cholecystokinin and gastrin receptors (CCK1R and CCK2R) which were delineated using experimental and computational methods, and then, we show how the validated ligand binding sites can be used to design and improve novel ligands. The translation of the knowledge of ligand-binding sites of different GPCRs to computer-aided design of novel ligands is summarized.
Tikhonova
Irina G
IG
INSERM, Institut National de la Santé et de la Recherche Médicale, Unit 531, Institut Fédératif de recherche, Toulouse, France.
Marco
Esther
E
Lahlou-Archer
Elodie
E
Langer
Ingrid
I
Foucaud
Magali
M
Maigret
Bernard
B
Fourmy
Daniel
D
D000818:Animals; D001665:Binding Sites; D002766:Cholecystokinin / Q000378:metabolism*; D003198:Computer Simulation; D015195:Drug Design; D006801:Humans; D008024:Ligands; D011949:Receptors, Cholecystokinin / Q000378:metabolism*; D015203:Reproducibility of Results
D008024:Ligands; D011949:Receptors, Cholecystokinin; D002766:Cholecystokinin